Center for Health Equity Research
Virtual Visit Request info Apply
MENUMENU
  • About
    • Our mission
    • CHER team
    • Affiliated faculty
    • Support CHER
  • Initiatives
    • Southwest Health Equity Research Collaborative (SHERC)
    • Diné College-NAU Collaboration
    • Black Hills Center for American Indian Health Collaboration
    • Community Health Workers
    • Health Equity for People With Disabilities
    • Criminal Justice and Public Health Interface
  • Projects
    • Current Projects
      • CEAL
      • Evaluating Arizona’s Health Start Program
      • Great Beginnings for Healthy Native Smiles
      • Impacts of the Gold King Mine Spill
      • Special Diabetes Program—Hualapai Tribe
    • Completed Projects
  • Resources
    • Reports
    • TAG Service Center
    • CHER Anti-Racism Resources
    • Regional Needs and Assets Assessment
    • Local, Regional, and National Resources
  • Training
    • C-CART: Culturally-Centered Addictions Research Training
    • Graduate Certificate in Translational Research Education in Adolescent Drug Abuse
    • Arizona Biomedical Research Center (ABRC) Education Series
  • Publications
  • News
  • Events
    • Upcoming events
    • Past events
  • NAU
  • CHER
  • CHER & SHERC news

Ladner develops method to detect complete history of viral exposures with a single test

Posted by ld583 on January 10, 2022

Funding for a Pilot Project Program through Northern Arizona University’s Southwest Health Equity Research Collaborative (SHERC) allowed Jason Ladner, assistant professor in the Department of Biological Sciences, to develop a unique “technological toolbox” that can identify and characterize antibodies against many different viruses simultaneously rather than only one at a time.

Called PepSeq, for peptide sequencing, Ladner’s technological toolbox was developed in close collaboration with John Altin, assistant professor in the Pathogen and Microbiome Division at the Translational Genomics Research Institute, or TGen, along with a team of researchers.

PepSeq is being applied to many viral antibody response projects already, including those involving SARS-CoV-2, and will be used more broadly in future research that assists in containing and combating viruses.

“A large part of this [PPP] project was focused on technology development, and this technology for highly-multiplexed serology [PepSeq] forms the basis for many of my ongoing and planned projects,” Ladner said.

PepSeq’s distinctive advancement in identifying and characterizing antibodies

Ladner, who works in NAU’s Pathogen and Microbiome Institute, said that during the past few decades, researchers have made great strides in understanding DNA––the molecule that carries genetic instructions in all living things.

“As a result, there has been a boom in genetic sequencing, which has included a big focus on the characterization of viral infections using molecular diagnostics and genome sequencing,” Ladner said. “Technologies associated with serological characterization, which identify antibodies circulating in the blood, have not advanced at the same rate, and can only detect antibodies against a single virus at a time rather than characterizing multiple viral exposures, as PepSeq does.”

Other complicating factors according to Ladner have been that “molecular [diagnostic] approaches … are limited to detecting active viral infections,” so “exactly the right sample type at the right time must be collected to allow for detection.”

Ladner said that antibodies, on the other hand, provide long-lived records of exposures to pathogens, including viruses, thus allowing for a more comprehensive view of viral exposure history.

Ladner’s PepSeq work

PepSeq uses large libraries of peptides tagged with DNA sequences to precisely identify particular peptides that are recognized by antibodies.

PepSeq technology was used to develop a highly-multiplexed assay, which is a biochemical test that uses protein-bound magnetic beads and high-throughput sequencing—a technology that quickly and successfully sequences DNA—to characterize an individual’s nearly complete history of viral exposures within a single test.
Ladner’s project results include:

  • A 244,000 peptide assay for highly-multiplexed serology, which broadly covers the full diversity of viruses known to infect humans.
  • A streamlined methodology for conducting PepSeq assays in the lab.
  • A custom, open source software package for processing the high-dimensional data generated from these assays.

PepSeq’s connection to health equity

Ladner said that despite well-documented disparities in infection rates for particular viruses, scientists still do not have a complete picture of virus-associated health disparities.

“Although these diseases are a global burden, there are also important gender and ethnicity-based health disparities associated with viral infections and therefore, viral-associated disease,” he said.

From his work, Ladner and his colleagues have already released two publications: “Epitope-resolved Profiling of the SARS-CoV-2 Antibody Response Identifies Cross-reactivity with Endemic Human Coronaviruses” and “PepSIRF: A Flexible and Comprehensive Tool for the Analysis of Data from Highly-multiplexed DNA-barcoded Peptide Assays.”

To connect this tool with health equity, Ladner also mentored NAU graduate Alejandra Piña with her Master of Science thesis, “Mapping Virus-Associated Health Disparities Utilizing Highly Multiplexed Serology.”

“We used this approach to broadly characterize differences in viral infection rates among Hispanic and non-Hispanic individuals in Phoenix,” Ladner said.

Ladner said following this study, he is now applying PepSeq to broadly characterize viral exposures in non-human animals.

“Our current understanding of the diversity and ecology of viruses in animals is very limited and expanding knowledge in this area is critical for future pandemic prevention,” Ladner said.

SHERC (U54MD012388), is sponsored by the National Institute on Minority Health and Health Disparities (NIMHD).

Filed Under: News

Categories

Tags

Alexandra Samarron Amanda Hunter Amanda Pollitt Amit Kumar AZ CEAL C-CART Carly Camplain Carmenlita Chief Carolyn Camplain Center for Health Equity Research CHER CHER/SHERC newsletter Community Health Workers COVID-19 COVID-19 and health equity Diné College Dr. Ricky Camplain Dulce Jimenez Emery Eaves Fairness First campaign Fairness First podcast health equity health promotion Heather Dreifuss Heather Williamson ISEP summer program Julie A. Baldwin Julie Baldwin Kalvina Belin Kristan Elwell Linnea Evans Mark Remiker Melinda Smith NARCH National Institute on Minority Health and Health Disparities NAU News Nicolette Teufel-Shone Omar Gomez Pilot Project Program research Ricky Camplain Samantha Sabo SHERC Southwest Health Equity Research Collaborative substance use

Archives

Home
Location
Room 110-140 Building 56
Applied Research and Development
1395 Knoles Drive
Flagstaff, Arizona 86011
Mailing Address
PO Box 4065
Flagstaff, Arizona 86011
Email
cher@nau.edu
Phone
928-523-9104
Social Media
Visit us on Twitter Facebook Instagram LinkedIn